Naoko Kajitani
Forskare vid Institutionen för medicinsk biokemi och mikrobiologi; Infektioner och immunitet; Stefan Schwartz
- E-post:
- naoko.kajitani@imbim.uu.se
- Besöksadress:
- BMC
Husargatan 3
752 37 UPPSALA - Postadress:
- Box 582
751 23 UPPSALA
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Senaste publikationer
- RNA elements that control human papillomavirus mRNA splicing-targets for therapy? (2024)
- HnRNP D activates production of HPV16 E1 and E6 mRNAs by promoting intron retention (2022)
- Overexpression of m6A-factors METTL3, ALKBH5, and YTHDC1 alters HPV16 mRNA splicing. (2022)
- Identification of heterogenous nuclear ribonucleoproteins (hnRNPs) and serine- and arginine-rich (SR) proteins that induce human papillomavirus type 16 late gene expression and alter L1 mRNA splicing (2022)
- hnRNP G/RBMX enhances HPV16 E2 mRNA splicing through a novel splicing enhancer and inhibits production of spliced E7 oncogene mRNAs (2022)
Alla publikationer
Artiklar
- RNA elements that control human papillomavirus mRNA splicing-targets for therapy? (2024)
- HnRNP D activates production of HPV16 E1 and E6 mRNAs by promoting intron retention (2022)
- Overexpression of m6A-factors METTL3, ALKBH5, and YTHDC1 alters HPV16 mRNA splicing. (2022)
- Identification of heterogenous nuclear ribonucleoproteins (hnRNPs) and serine- and arginine-rich (SR) proteins that induce human papillomavirus type 16 late gene expression and alter L1 mRNA splicing (2022)
- hnRNP G/RBMX enhances HPV16 E2 mRNA splicing through a novel splicing enhancer and inhibits production of spliced E7 oncogene mRNAs (2022)
- The role of RNA-binding proteins in the processing of mRNAs produced by carcinogenic papillomaviruses (2022)
